Clinical Support on the iFuse Implant System® | SI-BONE

Clinical Evidence

Safety, Effectiveness, and Reliability

Clinical evidence is imperative and we recognize that product safety, effectiveness, and reliability are critical factors for providing exceptional patient care. 

In this section

Clinical Evidence

Spotlight

Research on Prevalence 

of SI Joint Pain

  • 15-30% of individuals with lower back pain complaints actually had problems in their sacroiliac joint.1,2,3,4,5
  • 43% of post-lumbar fusion patients who were experiencing persistent or new onset lower back pain were shown to be symptomatic for SI joint disorders.14
Research on Prevalence of SI Joint Pain shows that 43% of post-lumbar fusion patients who were experiencing persistent or new onset lower back pain were shown to be symptomatic for SI joint disorders.

Rapid and Sustained Pain Relief: 

Rapid and Sustained Improvement 5 Year Outcomes from a Prospective Trail. At 12, 24 and 60 months, 82% of patients were satisfied and indicated that they would have the same surgery again for the same result.

iFuse: Backed By Evidence

The iFuse Implant System®, available since 2009, is the only device for treatment of SI joint dysfunction supported by significant published clinical evidence, including level 1 clinical data, showing safety, effectiveness and durability, including long lasting pain relief.

Pelvis closeup with 3D Implants

3,000+Treating Surgeons

75,000+iFuse Procedures Performed

100+iFuse Publications

Looking for Answers?

We can help. Tell us what you're looking for below.